Merus Labs International Inc. Co (MSLI) 2.37 $MSLI
Merus Labs International Inc. Announces Conversion of $10 Million Convertible Debentures
Marketwire - Thu Jul 17, 3:00PM CDT
Merus Labs International Inc. ("Merus" or the "Company"
(TSX: MSL)(NASDAQ: MSLI) is pleased to announce today that the Company has exercised its right to convert the $10 million unsecured convertible debentures (the "Convertible Debentures" issued to a large Canadian institutional investor in September 2013. The Company exercised its right based on the closing price of the Company's common shares having equalled or exceeded $2.30 per share for the 20 consecutive trading days ended July 14, 2014. In aggregate, the Company will issue 6,677,918 common shares to convert the outstanding $10 million principal amount plus accrued but unpaid interest.
Dacha releases audited financial statements for year ended March 31, 2014 and provides update on Merus transaction
CNW Group - Fri Jul 11, 3:15PM CDT
Dacha Strategic Metals Inc. (TSX-V: DSM) ("Dacha" today released its audited consolidated financial results for the year ended March 31, 2014 and provided an update on its pending transaction involving Merus Labs International Inc. ("Merus" . For more information, please see Dacha's audited consolidated financial statements and management's discussion and analysis filed under Dacha's profile on SEDAR at www.sedar.com. Unless otherwise noted, dollar references below are to U.S. funds.
Merus Labs International Inc. Announces Closing of $10 Million Preferred Share Financing
Marketwire - Fri Jul 11, 3:01PM CDT
Merus Labs International Inc. ("Merus" or the "Company" (TSX: MSL)(NASDAQ: MSLI) is pleased to announce today that the Company has completed its previously announced private placement issuance of $10 million of Series A convertible preferred shares (the "Series A Preferred Shares" to a large Canadian institutional investor. In aggregate, the Company issued 10,000 Series A Preferred Shares at a price of $1,000 per share for total proceeds of $10 million. The proceeds of the offering are expected to be used by the Company for future acquisition opportunities as well as for general corporate purposes. Additional details regarding the Series A Preferred Shares are provided in the Company's June 10, 2014 news release.
Dacha signs definitive acquisition agreement with Merus Labs International Inc.
CNW Group - Fri Jul 04, 3:33PM CDT
Dacha Strategic Metals Inc. (TSX-V: DSM) ("Dacha" announced today that it has entered into a definitive acquisition agreement with Merus Labs International Inc. ("Merus" (TSX: MSL, NASDAQ: MSLI) pursuant to which Dacha will complete the balance of its previously announced investment of at least $11 million in Merus.
Merus Signs Definitive Acquisition Agreement With Dacha Strategic Metals Inc.
Marketwire - Fri Jul 04, 3:01PM CDT
Merus Labs International Inc. ("Merus" or the "Company" (TSX: MSL)(NASDAQ: MSLI) today announced that it has entered into a definitive acquisition agreement with Dacha Strategic Metals Inc. ("Dacha" (TSX VENTURE: DSM) pursuant to which Dacha will complete the balance of the previously announced investment of at least $11 million in Merus.
Merus Labs International Inc. Announces Closing of $31.3 Million Bought Deal Financing, Including Exercise of Over-Allotment Option
Marketwire - Thu Jun 19, 7:46AM CDT
Merus Labs International Inc. ("Merus" or the "Company" (TSX: MSL)(NASDAQ: MSLI) is pleased to announce today the closing of its previously announced bought deal financing with a syndicate of investment dealers (the "Underwriters" . Under the financing, Merus issued a total of 18,400,000 common shares ("Shares" at a price of $1.70 per Share, inclusive of 2,400,000 common shares issued pursuant to the exercise in full of the over-allotment option by the Underwriters, for gross proceeds of $31,280,000.
Nasdaq stocks posting largest volume increases
AP - Tue Jun 17, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Merus to Present at Bloom Burton & Co. Healthcare Investor Conference
Marketwire - Mon Jun 16, 10:59AM CDT
Merus Labs International Inc. ("Merus" or the "Company" (TSX: MSL)(NASDAQ: MSLI) today announced that Mr. Elie Farah, the President & CEO of Merus, will present at the upcoming Bloom Burton & Co. Healthcare Investor Conference. Mr. Farah's presentation will take place on Wednesday, June 18th, 2014 at 1:30 P.M. (Eastern Time) at the Toronto Board of Trade, 1 First Canadian Place, Toronto, Ontario.
Dacha to participate in Merus Labs bought deal financing
CNW Group - Thu Jun 12, 10:22AM CDT
Dacha Strategic Metals Inc. (TSX-V: DSM) ("Dacha" announced today that it has agreed to subscribe for $5 million of common shares of Merus Labs International Inc. ("Merus" (TSX: MSL, NASDAQ: MSLI) at a price of $1.70 per share as part of the $27.2 million bought deal financing that Merus announced yesterday.
Merus Labs International Inc. Announces Increase to Previously Announced Financing
Marketwire - Thu Jun 12, 9:00AM CDT
Merus Labs International Inc. ("the Company" or "Merus" (TSX: MSL)(NASDAQ: MSLI) is pleased to announce that it has amended the terms of the previously announced bought deal public offering with a syndicate of investment dealers (the "Underwriters" to increase the size of the offering by an additional 3,000,000 common shares (the "Additional Common Shares" . Under the amended terms of the offering, the Underwriters have agreed to purchase an aggregate of 16,000,000 common shares ("Common Shares" of the Company for total gross proceeds of $27,200,000.
IIROC Trade Resumption - Merus Labs International Inc.
Newsfile Corp - Thu Jun 12, 7:02AM CDT
Trading resumes in:
IIROC Trade Resumption - MSL (all issues)
CNW Group - Thu Jun 12, 7:02AM CDT
Trading resumes in:
IIROC Trading Halt - MSL
CNW Group - Wed Jun 11, 3:31PM CDT
The following issues have been halted by IIROC:
Merus Labs International Inc. Announces Conversion of $10 Million Convertible Debentures
Marketwire - Thu Jul 17, 3:00PM CDT
Merus Labs International Inc. ("Merus" or the "Company"
(TSX: MSL)(NASDAQ: MSLI) is pleased to announce today that the Company has exercised its right to convert the $10 million unsecured convertible debentures (the "Convertible Debentures" issued to a large Canadian institutional investor in September 2013. The Company exercised its right based on the closing price of the Company's common shares having equalled or exceeded $2.30 per share for the 20 consecutive trading days ended July 14, 2014. In aggregate, the Company will issue 6,677,918 common shares to convert the outstanding $10 million principal amount plus accrued but unpaid interest. Dacha releases audited financial statements for year ended March 31, 2014 and provides update on Merus transaction
CNW Group - Fri Jul 11, 3:15PM CDT
Dacha Strategic Metals Inc. (TSX-V: DSM) ("Dacha"
today released its audited consolidated financial results for the year ended March 31, 2014 and provided an update on its pending transaction involving Merus Labs International Inc. ("Merus" . For more information, please see Dacha's audited consolidated financial statements and management's discussion and analysis filed under Dacha's profile on SEDAR at www.sedar.com. Unless otherwise noted, dollar references below are to U.S. funds. Merus Labs International Inc. Announces Closing of $10 Million Preferred Share Financing
Marketwire - Fri Jul 11, 3:01PM CDT
Merus Labs International Inc. ("Merus" or the "Company"
(TSX: MSL)(NASDAQ: MSLI) is pleased to announce today that the Company has completed its previously announced private placement issuance of $10 million of Series A convertible preferred shares (the "Series A Preferred Shares" to a large Canadian institutional investor. In aggregate, the Company issued 10,000 Series A Preferred Shares at a price of $1,000 per share for total proceeds of $10 million. The proceeds of the offering are expected to be used by the Company for future acquisition opportunities as well as for general corporate purposes. Additional details regarding the Series A Preferred Shares are provided in the Company's June 10, 2014 news release. Dacha signs definitive acquisition agreement with Merus Labs International Inc.
CNW Group - Fri Jul 04, 3:33PM CDT
Dacha Strategic Metals Inc. (TSX-V: DSM) ("Dacha"
announced today that it has entered into a definitive acquisition agreement with Merus Labs International Inc. ("Merus" (TSX: MSL, NASDAQ: MSLI) pursuant to which Dacha will complete the balance of its previously announced investment of at least $11 million in Merus. Merus Signs Definitive Acquisition Agreement With Dacha Strategic Metals Inc.
Marketwire - Fri Jul 04, 3:01PM CDT
Merus Labs International Inc. ("Merus" or the "Company"
(TSX: MSL)(NASDAQ: MSLI) today announced that it has entered into a definitive acquisition agreement with Dacha Strategic Metals Inc. ("Dacha" (TSX VENTURE: DSM) pursuant to which Dacha will complete the balance of the previously announced investment of at least $11 million in Merus. Merus Labs International Inc. Announces Closing of $31.3 Million Bought Deal Financing, Including Exercise of Over-Allotment Option
Marketwire - Thu Jun 19, 7:46AM CDT
Merus Labs International Inc. ("Merus" or the "Company"
(TSX: MSL)(NASDAQ: MSLI) is pleased to announce today the closing of its previously announced bought deal financing with a syndicate of investment dealers (the "Underwriters" . Under the financing, Merus issued a total of 18,400,000 common shares ("Shares" at a price of $1.70 per Share, inclusive of 2,400,000 common shares issued pursuant to the exercise in full of the over-allotment option by the Underwriters, for gross proceeds of $31,280,000. Nasdaq stocks posting largest volume increases
AP - Tue Jun 17, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Merus to Present at Bloom Burton & Co. Healthcare Investor Conference
Marketwire - Mon Jun 16, 10:59AM CDT
Merus Labs International Inc. ("Merus" or the "Company"
(TSX: MSL)(NASDAQ: MSLI) today announced that Mr. Elie Farah, the President & CEO of Merus, will present at the upcoming Bloom Burton & Co. Healthcare Investor Conference. Mr. Farah's presentation will take place on Wednesday, June 18th, 2014 at 1:30 P.M. (Eastern Time) at the Toronto Board of Trade, 1 First Canadian Place, Toronto, Ontario. Dacha to participate in Merus Labs bought deal financing
CNW Group - Thu Jun 12, 10:22AM CDT
Dacha Strategic Metals Inc. (TSX-V: DSM) ("Dacha"
announced today that it has agreed to subscribe for $5 million of common shares of Merus Labs International Inc. ("Merus" (TSX: MSL, NASDAQ: MSLI) at a price of $1.70 per share as part of the $27.2 million bought deal financing that Merus announced yesterday. Merus Labs International Inc. Announces Increase to Previously Announced Financing
Marketwire - Thu Jun 12, 9:00AM CDT
Merus Labs International Inc. ("the Company" or "Merus"
(TSX: MSL)(NASDAQ: MSLI) is pleased to announce that it has amended the terms of the previously announced bought deal public offering with a syndicate of investment dealers (the "Underwriters" to increase the size of the offering by an additional 3,000,000 common shares (the "Additional Common Shares" . Under the amended terms of the offering, the Underwriters have agreed to purchase an aggregate of 16,000,000 common shares ("Common Shares" of the Company for total gross proceeds of $27,200,000. IIROC Trade Resumption - Merus Labs International Inc.
Newsfile Corp - Thu Jun 12, 7:02AM CDT
Trading resumes in:
IIROC Trade Resumption - MSL (all issues)
CNW Group - Thu Jun 12, 7:02AM CDT
Trading resumes in:
IIROC Trading Halt - MSL
CNW Group - Wed Jun 11, 3:31PM CDT
The following issues have been halted by IIROC:
